Header Template - Free News - PharmProm.Net - Pharmaceutical Industry Information Portal

PHARMPROM is a premier digital resource for the pharmaceutical sector, combining breaking news, deep insights, and key market events. We cover the entire product lifecycle—from R&D and manufacturing to distribution—in strict accordance with Good Pharmaceutical Practices (GxP).

Disclaimer All content on pharmprom.net is for informational purposes only and does not constitute medical advice. The materials are intended exclusively for industry professionals and are not addressed to the general public.

Japan Becomes First in the World to Approve iPS Cell-Based Therapy for Parkinson’s Disease

IQVIA Enters the Early-Stage Drug Development Market by Acquiring Charles River Laboratories Assets

Pharmaceutical Logistics Operator Santens Group Transfers to Russian Jurisdiction

EBRD to Finance the Expansion of Pharmaceutical Production in Uzbekistan with €20 Million

GMP Registry Update: 8 New Certificates by the End of February 2026

Vadim Kukava: The Pharmaceutical Industry Should Not Be Divided into “Theirs” and “Ours”

Top Ten Most Anticipated Drug Launches of 2026 That Will Reshape the Global Market

The Paradox of Russian Pharma: About 700 Pharmaceutical Companies Operate in Russia Without GMP Certificates

Japan Becomes First in the World to Approve iPS Cell-Based Therapy for Parkinson’s Disease

A Line of Eight Probiotic-Based Edible Vaccines Developed in Russia

Eli Lilly and Nvidia Launch LillyPod — The Most Powerful AI Supercomputer in Global Pharma

Sechenov University Unveils World’s First Effective CRISPR Delivery System

PHARMPROM Portal Becomes a Media Partner of the International Pharmacovigilance World 2026 Conference

Session “EAEU’s common market of medicinal products for veterinary use” at the All-Russian GMP Conference 2025

Moscow Hosts the X GMP Conference Under the Motto “Regulating Today — Creating a Stable Tomorrow”

Pharmtech & Ingredients International Exposition 2022 Results

Japan Becomes First in the World to Approve iPS Cell-Based Therapy for Parkinson’s Disease

IQVIA Enters the Early-Stage Drug Development Market by Acquiring Charles River Laboratories Assets

Pharmaceutical Logistics Operator Santens Group Transfers to Russian Jurisdiction

EBRD to Finance the Expansion of Pharmaceutical Production in Uzbekistan with €20 Million

GMP Registry Update: 8 New Certificates by the End of February 2026

Vadim Kukava: The Pharmaceutical Industry Should Not Be Divided into “Theirs” and “Ours”

Top Ten Most Anticipated Drug Launches of 2026 That Will Reshape the Global Market

The Paradox of Russian Pharma: About 700 Pharmaceutical Companies Operate in Russia Without GMP Certificates

Japan Becomes First in the World to Approve iPS Cell-Based Therapy for Parkinson’s Disease

A Line of Eight Probiotic-Based Edible Vaccines Developed in Russia

Eli Lilly and Nvidia Launch LillyPod — The Most Powerful AI Supercomputer in Global Pharma

Sechenov University Unveils World’s First Effective CRISPR Delivery System

PHARMPROM Portal Becomes a Media Partner of the International Pharmacovigilance World 2026 Conference

Session “EAEU’s common market of medicinal products for veterinary use” at the All-Russian GMP Conference 2025

Moscow Hosts the X GMP Conference Under the Motto “Regulating Today — Creating a Stable Tomorrow”

Pharmtech & Ingredients International Exposition 2022 Results

Company

Headlines

Japan Becomes First in the World to Approve iPS Cell-Based Therapy for Parkinson’s Disease

IQVIA Enters the Early-Stage Drug Development Market by Acquiring Charles River Laboratories Assets

Pharmaceutical Logistics Operator Santens Group Transfers to Russian Jurisdiction

A Line of Eight Probiotic-Based Edible Vaccines Developed in Russia

Newsletter